The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Clinical Outbreak of Linezolid-Resistant <emph type="ital">Staphylococcus aureus</emph> in an Intensive Care Unit
Abstract
CONTEXT: Linezolid resistance is extremely uncommon in Staphylococcus aureus. OBJECTIVE: To report an outbreak with linezolid and methicillin-resistant S. aureus (LRSA) in an intensive care department and the effective control measures taken. DESIGN, SETTING, AND PATIENTS: Outbreak study of consecutive critically ill patients colonized and/or infected with LRSA at an intensive care department of a 1000-bed tertiary care university teaching hospital in Madrid, Spain. Patients were placed under strict contact isolation. Daily updates of outbreak data and recommendations for the use of linezolid were issued. Extensive environmental sampling and screening of the hands of health care workers were performed. MAIN OUTCOME MEASURES: Linezolid use and clinical and epidemiological characteristics and outcomes using minimal inhibitory concentrations, pulsed-field gel electrophoresis, and polymerase chain reaction of LRSA isolates. RESULTS: Between April 13 and June 26, 2008, 12 patients with LRSA were identified. In 6 patients, LRSA caused ventilator-associated pneumonia and in 3 patients it caused bacteremia. Isolates were susceptible to trimethoprim-sulfamethoxazole, glycopeptides, tigecycline, and daptomycin. Genotyping identified 1 predominant clone and 3 other types. Cfr-mediated linezolid resistance was demonstrated in all isolates. Potential hospital staff carriers and environmental samples were negative except for one. Six patients died, 5 of them in the intensive care unit, with 1 death attributed to LRSA infection. Linezolid use decreased from 202 defined daily doses in April 2008 to 25 defined daily doses in July 2008. Between July 2008 and April 2010, no new cases have been identified in the weekly surveillance cultures or diagnostic samples. CONCLUSIONS: The first clinical outbreak, to our knowledge, with LRSA mediated by the cfr gene developed at our center, was associated with nosocomial transmission and extensive usage of linezolid. Reduction of linezolid use and infection-control measures were associated with the termination of the outbreak.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vincent, J. L., Moreno, R., Takala, J., Willatts, S., De Mendonça, A., Bruining, H., Reinhart, C. K., Suter, P. M., & Thijs, L. G. (1996) · Intensive Care Medicine · doi:10.1007/bf01709751 · Cited by 11,674
Tenover, F. C., Arbeit, R. D., Goering, R. V., Mickelsen, P. A., Murray, B. E., Persing, D. H., & Swaminathan, B. (1995) · Journal of Clinical Microbiology · doi:10.1128/jcm.33.9.2233-2239.1995 · Cited by 8,204
Klevens, R. M. (2007) · JAMA · doi:10.1001/jama.298.15.1763 · Cited by 3,726
Linezolid resistance in a clinical isolate of Staphylococcus aureus
Tsiodras, S., Gold, H. S., Sakoulas, G., Eliopoulos, G. M., Wennersten, C., Venkataraman, L., Moellering, R. C., & Ferraro, M. J. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05410-1 · Cited by 1,033
Long, K. S., Poehlsgaard, J., Kehrenberg, C., Schwarz, S., & Vester, B. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00131-06 · Cited by 708
Wayne, P. A. (2011) · Cited by 705
Murchan, S., Kaufmann, M. E., Deplano, A., de Ryck, R., Struelens, M., Zinn, C. E., Fussing, V., Salmenlinna, S., Vuopio-Varkila, J., El Solh, N., et al. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.4.1574-1585.2003 · Cited by 637
Howden, B. P., Ward, P. B., Charles, P. G. P., Korman, T. M., Fuller, A., Cros, P. D., Grabsch, E. A., Roberts, S. A., Robson, J., Read, K., et al. (2004) · Clinical Infectious Diseases · doi:10.1086/381202 · Cited by 484
Toh, S., Xiong, L., Arias, C. A., Villegas, M. V., Lolans, K., Quinn, J., & Mankin, A. S. (2007) · Molecular Microbiology · doi:10.1111/j.1365-2958.2007.05744.x · Cited by 338
Linezolid: The First Oxazolidinone Antimicrobial
Paterson, D. L., Pasculle, A. W., & McCurry, K. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-10-200311180-00017 · Cited by 328
Kollef, M. H., Rello, J., Cammarata, S. K., Croos-Dabrera, R. V., & Wunderink, R. G. (2004) · Intensive Care Medicine · doi:10.1007/s00134-003-2088-1 · Cited by 315
Morales, G., Picazo, J. J., Baos, E., Candel, F. J., Arribi, A., Peláez, B., Andrade, R., de la Torre, M., Fereres, J., & Sánchez‐García, M. (2010) · Clinical Infectious Diseases · doi:10.1086/650574 · Cited by 292
Self-citationLinezolid resistance in clinical isolates of Staphylococcus aureus
Wilson, P. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg104 · Cited by 289
Meka, V. G., Pillai, S. K., Sakoulas, G., Wennersten, C., Venkataraman, L., DeGirolami, P. C., Eliopoulos, G. M., Moellering, Jr., & Gold, H. S. (2004) · The Journal of Infectious Diseases · doi:10.1086/421471 · Cited by 247
Mendes, R. E., Deshpande, L. M., Castanheira, M., DiPersio, J., Saubolle, M. A., & Jones, R. N. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00231-08 · Cited by 226
Struelens, M. J., Deplano, A., Godard, C., Maes, N., & Serruys, E. (1992) · Journal of Clinical Microbiology · doi:10.1128/jcm.30.10.2599-2605.1992 · Cited by 216
Rahim, S., Pillai, S. K., Gold, H. S., Venkataraman, L., Inglima, K., & Press, R. A. (2003) · Clinical Infectious Diseases · doi:10.1086/374929 · Cited by 129
Gales, A. C., Sader, H. S., ANDRADE, S., Lutz, L., MACHADO, A., & Barth, A. L. (2006) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2005.11.008 · Cited by 124
United States resistance surveillance results for linezolid (LEADER Program for 2007)
Jones, R. N., Ross, J. E., Castanheira, M., & Mendes, R. E. (2008) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2008.10.010 · Cited by 101
Reversion to susceptibility in a linezolid-resistant clinical isolate of Staphylococcus aureus
Meka, V. G., Gold, H. S., Cooke, A., Venkataraman, L., Eliopoulos, G. M., Moellering, R. C., & Jenkins, S. G. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh423 · Cited by 89
Kelly, S., Collins, J., Maguire, M., Gowing, C., Flanagan, M., Donnelly, M., & Murphy, P. G. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn043 · Cited by 81
Álvarez-Lerma, F., Palomar, M., Olaechea, P., Otal, J. J., Insausti, J., & Cerdá, E. (2007) · Medicina Intensiva · doi:10.1016/s0210-5691(07)74764-2 · Cited by 79
Jones, R. N., Kohno, S., Ono, Y., Ross, J. E., & Yanagihara, K. (2009) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2009.03.001 · Cited by 77
Clinical Characteristics of Linezolid-Resistant Staphylococcus aureus Infections
Peeters, M. J., & Sarria, J. C. (2005) · The American Journal of the Medical Sciences · doi:10.1097/00000441-200508000-00007 · Cited by 67
Ruggero, K. A., Schroeder, L. K., Schreckenberger, P. C., Mankin, A. S., & Quinn, J. P. (2003) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(03)00153-6 · Cited by 62
Schulte, B., Heininger, A., Autenrieth, I. B., & Wolz, C. (2007) · Epidemiology and Infection · doi:10.1017/s0950268807009508 · Cited by 46
Enterococcus faecalis Resistant to Linezolid: Case Series and Review of the Literature
Burleson, B. S., Ritchie, D. J., Micek, S. T., & Dunne, W. M. (2004) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.24.13.1225.38086 · Cited by 40
An infection with linezolid-resistant S. aureus in a patient with left ventricular assist system
Kola, A., Kirschner, P., Gohrbandt, B., Chaberny, I. F., Mattner, F., Strüber, M., Gastmeier, P., & Suerbaum, S. (2006) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540601071875 · Cited by 13
Cited by
Liu, C., Bayer, A., Cosgrove, S. E., Daum, R. S., Fridkin, S. K., Gorwitz, R. J., Kaplan, S. L., Karchmer, A. W., Levine, D. P., Murray, B. E., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq146 · Cited by 4,191
A meta-analysis of randomized controlled trials: Efficacy of selenium treatment for sepsis
Li, S., Tang, T., Guo, P., Zou, Q., Ao, X., Hu, L., & Tan, L. (2019) · Medicine · doi:10.1097/md.0000000000014733 · Cited by 802
Resistance to Linezolid Caused by Modifications at Its Binding Site on the Ribosome
Long, K. S., & Vester, B. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05702-11 · Cited by 375
Methicillin-Resistant Staphylococcus aureus Therapy: Past, Present, and Future
Rodvold, K. A., & McConeghy, K. W. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/cit614 · Cited by 358
The Global Spread of Healthcare-Associated Multidrug-Resistant Bacteria: A Perspective From Asia
Molton, J. S., Tambyah, P. A., Ang, B. S. P., Ling, M. L., & Fisher, D. A. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit020 · Cited by 342
Metadata
- Authors
- Sánchez García, M.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2010-06-09
- Volume
- 303
- Issue
- 22
- Pages
- 2260
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2142827309
- Cited by
- 270
- References
- 28
- FWCI
- 23.25
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.